SK

Sushma Kattamuri

Active Director Director DIN 02986836
DIN 02986836 First appointment Jul 2010 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 5 historical roles
Total affiliations 9 Since Jul 2010
Shareholding value •••• Premium profile

About Sushma Kattamuri

Data last updated:

Sushma Kattamuri is a Director at Priche Generics Private Limited (since 2024), Director at Evertogen Life Sciences Limited (since 2022) and Director at Lytica Labs Private Limited (since 2024), and holds 1 more current directorship. The companies operate in Pharma, Business Services and Financial Services. The 4 current companies with reported revenue have a combined latest revenue of ₹186 Cr; the largest is Priche Generics Private Limited at ₹96.36 Cr (FY 2025). Earlier, Sushma Kattamuri was a Designated Partner at Northway Advisors Llp (2012–2024) and Director at Aryakube Capital Private Limited (2016) and 3 more.

DIN 02986836
Primary Designation Director
Industry Pharma
First Appointment 20 Jul 2010
Oldest Company Age 24 yrs
Largest company Priche Generics Private Limited · ₹96.36 Cr (FY 2025)
Combined revenue ₹186 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Priche Generics Private Limited U74999TG2016PTC112294
Director10 Aug 20242016₹96.36 Cr (FY 2025)Active
Evertogen Life Sciences Limited U24232TG2013PLC085349
Director05 Jan 20222013₹89.28 Cr (FY 2024)Active
Lytica Labs Private Limited U74999TG2017PTC120942
Director02 Sep 20242017₹13.5 Lakh (FY 2025)Active
Director13 Aug 20242002₹6.3 Lakh (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner06 Nov 20122012Active
Aryakube Capital Private Limited U93000TG2016PTC102781
Director19 Jan 20162016₹5.40 Cr (FY 2025)Active
Director20 Jul 20102010Amalgamated
Director25 Apr 20162016₹24,145 (FY 2017)Strike Off
Director29 Oct 20152015₹29,997 (FY 2021)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Gil Agrotech ( India ) Private Limited
Evertogen Life Sciences Limited
Happy Advisory Services & Consulting Private Limited
Perfin Advisory Services Private Limited
Premium access

Shareholding and investment profile for Sushma Kattamuri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sushma Kattamuri

Sushma Kattamuri currently holds 4 directorships: Priche Generics Private Limited (Director, since 10 Aug 2024, revenue ₹96.36 Cr (FY 2025)); Evertogen Life Sciences Limited (Director, since 05 Jan 2022, revenue ₹89.28 Cr (FY 2024)); Lytica Labs Private Limited (Director, since 02 Sep 2024, revenue ₹13.5 Lakh (FY 2025)); K.R.R. Drugs & Intermediates Private Limited (Director, since 13 Aug 2024, revenue ₹6.3 Lakh (FY 2025)).

Sushma Kattamuri was first appointed on 20 Jul 2010 as Director at Gil Agrotech ( India ) Private Limited. The most recent appointment on record is 02 Sep 2024 at Lytica Labs Private Limited.

The 4 current companies of Sushma Kattamuri that report revenue have a combined latest revenue of ₹186 Cr: Priche Generics Private Limited ₹96.36 Cr (FY 2025); Evertogen Life Sciences Limited ₹89.28 Cr (FY 2024); Lytica Labs Private Limited ₹13.5 Lakh (FY 2025); K.R.R. Drugs & Intermediates Private Limited ₹6.3 Lakh (FY 2025).

Sushma Kattamuri held 5 earlier board appointments: Northway Advisors Llp (Designated Partner, 06 Nov 2012 to 16 Jul 2024); Aryakube Capital Private Limited (Director, 19 Jan 2016 to 20 May 2016); Gil Agrotech ( India ) Private Limited (Director, from 20 Jul 2010); Happy Advisory Services & Consulting Private Limited (Director, from 25 Apr 2016); Perfin Advisory Services Private Limited (Director, from 29 Oct 2015).

The current boards of Sushma Kattamuri's companies include Subbarao Kattamuri (Priche Generics Private Limited), Akhila Thotapally (Evertogen Life Sciences Limited), Manav Jassal (Evertogen Life Sciences Limited), Sat Paul Jassal (Evertogen Life Sciences Limited), Sherifuddin Sheriff Shaik (Evertogen Life Sciences Limited), Vikram Ravindra Mamidipudi (Evertogen Life Sciences Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available